Two studies by researchers from cancer centers across the US found that scalp cooling devices can often help reduce hair loss during chemotherapy.
In 2016, the FDA approved several new drug treatments for different cancer types that American Cancer Society editors believe will make a significant difference.
A study by researchers from leading cancer centers across the US has found that modern chemotherapy treatments have only a small impact on the ability of female childhood and adolescent cancer survivors to have children when they grow up. However, male survivors are more likely to have fertility problems.
The US Food and Drug Administration (FDA) has approved the chemotherapy drug Halaven (eribulin) to treat liposarcoma, a type of soft tissue sarcoma.